MedPath

Magnesium Sulfate and Neuroendocrine Hormone

Phase 4
Conditions
Arthropathy of Knee
Cortisol
Magnesium Sulfate
Dehydroepiandrosterone
Interventions
Drug: Isotonic Saline
Registration Number
NCT04514731
Lead Sponsor
Seoul National University Hospital
Brief Summary

Total knee arthroplasty is a procedure that relieves pain in patients with severe symptomatic osteoarthritis, but it can be associated with postoperative pain, which hinders recovery. In the previous study, we reported evidence of increased pain in patients undergoing staged total knee arthroplasty, in whom the second operated knee had greater sensitivity (tertiary hyperalgesia) as a result of the surgical injury to the first operated knee.

Magnesium sulfate is an effective analgesic adjuvant for postoperative pain. Its analgesic property seems to be associated with the regulation of calcium influx into the cells, or antagonism of N-methyl-D-aspartate receptors in the central nervous system. Additionally, magnesium is known to have an anti-inflammatory effect. Inflammatory state may accompany with pain via peripheral or central sensitization.

Recently, we reported that magnesium sulfate effectively attenuates not only postoperative pain but also increased pain intensity without serious adverse effects in the bilateral staged total knee arthroplasty. However, the exact mechanism regarding these effects of magnesium sulfate remains unclear.

In the present study, we will investigate the analgesic mechanism of magnesium sulfate via analysis of endocrine neurosteroid levels in patients undergoing bilateral staged total knee arthroplasty.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • Patients who undergo staged bilateral total knee arthroplasty
  • Spinal anesthesia
  • American Society of Anesthesiologists physical status 1 and 2
Exclusion Criteria
  • Patients who undergo unilateral total knee arthroplasty
  • General anesthesia
  • Musculoskeletal disease
  • Hypermagnesemia
  • Atrioventricular block
  • Previous history of administration of calcium channel blockers

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group SIsotonic SalinePatients in the saline group received the same volume of isotonic saline over the same period with magnesium infusion protocol
Group MMagnesium sulfatePatients in the magnesium sulfate group received magnesium sulfate 50 mg/kg for 15 minutes after spinal anesthesia and then 15 mg/kg/hour by continuous intravenous infusion until the end of surgery
Primary Outcome Measures
NameTimeMethod
The profiles of cortisol in the salivaFrom the evening (21:00) before the operation day to the morning (60 minutes after wake-up) of the operation day, for each stage of the operation

The cortisol concentrations in the saliva, at the evening before the operation (21:00\~22:00), just after wake-up in the morning of the operation day, and 30 and 60 minutes after wake-up

The profiles of dehydroepiandrosterone (DHEA) in the salivaFrom the evening (21:00) before the operation day to the morning (60 minutes after wake-up) of the operation day, for each stage of the operation

The DHEA concentrations in the saliva, at the evening before the operation (21:00\~22:00), just after wake-up in the morning of the operation day, and 30 and 60 minutes after wake-up

Secondary Outcome Measures
NameTimeMethod
Anti-emeticsPostoperative 48 hour

Amounts of anti-emetics consumption

Postoperative painPostoperative 48 hour

Numerical rating scale pain score

Patient controlled analgesia (PCA)Postoperative 48 hour

Amounts of PCA consumption

NauseaPostoperative 48 hour

Incidence of nausea

VomitingPostoperative 48 hour

Incidence of vomiting

Trial Locations

Locations (1)

Seoul National University Bundang Hospital

🇰🇷

Seongnam-si, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath